natgillin/translations-raw huggingface dataset:
Farmakoterapeutisk klassifikation: Midler der virker på renin-angiotensin-systemet; angiotensin-II- antagonister, kombinationer; angiotensin-II-antagonister og calciumkanal-blokkere, ATC-kode: C09DB01
Pharmacotherapeutic group: Agents acting on the renin-angiotensin system; angiotensin II antagonists, combinations; angiotensin II antagonists and calcium channel blockers, ATC code: C09DB01
Farmakoterapeutisk klassifikation: Midler med virkning på renin-angiotensin-systemet, angiotensin II- antagonister og calciumantagonister; ATC-kode: C09DB04.
Pharmacotherapeutic group: Agents acting on the renin-angiotensin system, angiotensin II antagonists and calcium channel blockers; ATC Code: C09DB04.
Farmakoterapeutisk klassifikation: Midler med virkning på renin-angiotensin-systemet; angiotensin-II- antagonister, andre kombinationer, ATC-kode: C09DX04
Pharmacotherapeutic group: Agents acting on the renin-angiotensin system; angiotensin II antagonists, other combinations, ATC code: C09DX04
Farmakoterapeutisk klassifikation: midler mod anæmi, andre midler mod anæmi, ATC-kode: B03XA02.
Pharmacotherapeutic group: Anti-anaemic preparations, other antianemic preparations, ATC Code: B03XA02.
Farmakoterapeutisk klassifikation: Midler mod anæmi, ATC-kode: B03XA01
Pharmacotherapeutic group: antianemic, ATC code: B03XA01 Mechanism of action
Farmakoterapeutisk klassifikation: Midler mod anæmi, ATC-kode: B03XA01 Virkningsmekanisme
Pharmacotherapeutic group: antianemic, ATC code: B03XA01 Mechanism of action
Farmakoterapeutisk klassifikation: Midler mod artritis urica, andre midler mod artritis urica, ATC- kode: M04AX02
Pharmacotherapeutic group: Anti-gout preparations, other anti-gout preparations, ATC code: M04AX02
Farmakoterapeutisk klassifikation: Midler mod obstruktiv luftvejssygdom, adrenergika i kombination med kortikosteroider/andre lægemidler ekskl. antikolinergika, ATC-kode: R03AK06
Pharmacotherapeutic group: Drugs for obstructive airway diseases, adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics, ATC code: R03AK06
Farmakoterapeutisk klassifikation: Midler mod obstruktiv lungesygdom, adrenergika i kombination med antikolinergika, ATC-kode: R03AL03.
Pharmacotherapeutic group: Drugs for obstructive airway diseases, adrenergics in combination with anticholinergics, ATC code: R03AL03
Farmakoterapeutisk klassifikation: Midler mod obstruktiv lungesygdom, adrenergika og andre midler mod obstruktiv lungesygdom, ATC-kode: R03AK10.
Pharmacotherapeutic group: Drugs for obstructive airways diseases, Adrenergics and other drugs for obstructive airway diseases, ATC code: R03AK10.
Farmakoterapeutisk klassifikation: Midler til arvelig angioødem, C1-hæmmer, plasmaderiveret, ATC-kode: B06AC01.
Pharmacotherapeutic group: Drugs used in hereditary angioedema, C1 inhibitor, plasma derived, ATC code: B06AC01.
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme - Andre lægemidler med virkning på knoglestruktur og –mineralisering, ATC-kode: M05BX03.
Pharmacotherapeutic group: Drugs for the treatment of bone diseases - Other drugs affecting bone structure and mineralisation, ATC code: M05BX03.
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme – andre lægemidler, med virkning på knoglestruktur og mineralisering, ATC-kode: M05BX04
Pharmacotherapeutic group: Drugs for the treatment of bone diseases – other drugs affecting bone structure and mineralisation, ATC code: M05BX04
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme – andre lægemidler, med virkning på knoglestruktur og mineralisering, ATC-kode: M05BX04
Pharmacotherapeutic group: Drugs for the treatment of bone diseases – Other drugs affecting bone structure and mineralization, ATC code: M05BX04
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisfosfonater, ATC- kode: M05BA08
Pharmacotherapeutic group: Drugs for treatment of bone diseases, bisphosphonates ATC code: M05BA08
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisfosfonater, ATC- kode: M05BA08
Pharmacotherapeutic group: Drugs for treatment of bone diseases, bisphosphonates, ATC code: M05BA08
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisfosfonater, ATC-kode: M05BA08
Pharmacotherapeutic group: Drugs affecting bone structure and mineralization, bisphosphonates, ATC code: M05BA08
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisphosphonater ATC- kode: M05BA06
Pharmacotherapeutic group: Medicinal products for treatment of bone diseases, bisphosphonate, ATC Code: M05BA06
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisphosphonater, ATC- kode: M05BA06
Pharmaco-therapeutic group: Medicinal products for treatment of bone diseases, bisphosphonate, ATC Code: M05BA06
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisphosphonater, ATC- kode: M05BA06
Pharmaco-therapeutic group: Medicinal products for treatment of bone diseases, bisphosphonate, ATC Code: M05BA06.
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisphosphonater, ATC- kode: M05BA06
Pharmacotherapeutic group: Medicinal products for treatment of bone diseases, bisphosphonates, ATC code: M05-BA06
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisphosphonater, ATC- kode: M05BA06
Pharmacotherapeutic group: Medicinal products for treatment of bone diseases, bisphosphonates, ATC code: M05BA06
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisphosphonater, ATC- kode: M05BA06.
Pharmaco-therapeutic group: Medicinal products for treatment of bone diseases, bisphosphonate, ATC Code: M05BA06.
Farmakoterapeutisk klassifikation: Midler til behandling af knoglesygdomme, bisphosphonater, ATC- kode: M05BA06.
Pharmacotherapeutic group: Medicinal products for treatment of bone diseases, bisphosphonates, ATC code: M05BA06
Farmakoterapeutisk klassifikation: Midler til nuklearmedicinske undersøgelser, tumordetektion, ATC- kode: V09IA09
Pharmacotherapeutic group: diagnostic radiopharmaceutical, tumour detection, ATC Code: V09IA09.
Farmakoterapeutisk klassifikation: monoklonale antistoffer, ATC-kode: L01XC10 Virkningsmekanisme
Pharmacotherapeutic group: monoclonal antibodies, ATC code: L01XC10 Mechanism of action
Farmakoterapeutisk klassifikation: Nasale præparater og dekongestanter til systemisk brug, ATC- kode: R01BA52.
Pharmacotherapeutic group: Nasal preparations, nasal decongestants for systemic use, ATC code: R01BA52.
Farmakoterapeutisk klassifikation: Oftalmologika, Andre oftalmologika, ATC-kode: S01XA22 Virkningsmekanisme
Pharmacotherapeutic group: Ophthalmologicals, Other ophthalmologicals, ATC code: S01XA22 Mechanism of action
Farmakoterapeutisk klassifikation: Oftalmologika, antiglaukommidler og miotika, prostaglandin-analoger.
Pharmacotherapeutic Group: Ophthalmologicals-antiglaucoma preparations and miotics-prostaglandin analogues
Farmakoterapeutisk klassifikation: Oftalmologiske lægemidler, antiglaukommiddel og miotika ATC-kode: S01 ED 51
Pharmacotherapeutic group: Ophthalmologicals, Antiglaucoma preparation and miotics ATC code: S01ED51
Farmakoterapeutisk klassifikation: Oftalmologiske lægemidler, antiglaukommiddel og miotika, ATC-kode: S01EC54
Pharmacotherapeutic group: Ophthalmologicals, Antiglaucoma preparation and miotics ATC code: S01EC54
Farmakoterapeutisk klassifikation: Oftalmologiske midler: Antiglaukom-præparater og miotika: ACT-kode: S01EE04
Pharmacotherapeutic Group: Ophthalmologicals, antiglaucoma preparations and miotics, ATC code: S01EE04
Farmakoterapeutisk klassifikation: Ophthalmologica, antineovaskulære midler, ATC-kode: S01LA01 Verteporfin, som også betegnes benzoporphyrin monosyrederivat (BPD-MA), består af en
Pharmacotherapeutic group: Ophthalmologicals, Antineovascularisation agents, ATC code: S01LA01 Verteporfin, also referred to as benzoporphyrin derivative monoacids (BPD-MA) consists of a
Farmakoterapeutisk klassifikation: perifert virkende muskelrelaksantia, ATC-kode: M03AX 01
Pharmacotherapeutic group: muscle relaxant, peripherally acting agents, ATC code: M03AX 01
Farmakoterapeutisk klassifikation: pneumokokvacciner, ATC-kode: J07AL52
Pharmacotherapeutic group: pneumococcal vaccines, ATC code: J07AL52
Farmakoterapeutisk klassifikation: proteasehæmmer, ATC-kode: J05A E05 Virkningsmekanisme
Pharmacotherapeutic group: protease inhibitor; ATC Code: J05A E05 Mechanism of Action
Farmakoterapeutisk klassifikation: proteasehæmmer, ATC-kode: J05A E05 Virkningsmekanisme
Pharmacotherapeutic group; protease inhibitor; ATC Code: J05A E05 Mechanism of Action
Farmakoterapeutisk klassifikation: Protein-kinasehæmmer, ATC-kode: L01XE01 Virkningsmekanisme
Pharmacotherapeutic group: antineoplastic agents, protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapeutisk klassifikation: Protein-kinasehæmmer, ATC-kode: L01XE01 Virkningsmekanisme
Pharmacotherapeutic group: protein kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapeutisk klassifikation: Protein-tyrosinkinasehæmmer, ATC-kode: L01XE01 Virkningsmekanisme
Pharmacotherapeutic group: protein-tyrosine kinase inhibitor, ATC code: L01XE01 Mechanism of action
Farmakoterapeutisk klassifikation: Psykoanaleptika, Andre antidepressiva, ATC-kode: N06AX22 Virkningsmekanisme
Pharmacotherapeutic group: Psychoanaleptics, other antidepressants, ATC-code: N06AX22 Mechanism of action
Farmakoterapeutisk klassifikation: Psykoanaleptika, xantinderivater, ATC-kode: N06BC01 Virkningsmekanisme
Pharmacotherapeutic group: Psychoanaleptics, xanthine derivatives ATC code: N06BC01 Mechanism of action
Farmakoterapeutisk klassifikation: Psykoanaleptika: Andre antidepressiva, ATC-kode: N06AX26 Virkningsmekanisme
Pharmacotherapeutic group: Psychoanaleptics; Other antidepressants, ATC-code: N06AX26 Mechanism of action
Farmakoterapeutisk klassifikation: Psykokeptika, diazepiner, oxazepiner, thiazepiner og oxepiner.
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines thiazepines and oxepines.
Farmakoterapeutisk klassifikation: Psykoleptika, andre antipsykotika ATC-kode: N05AX13 INVEGA indeholder en racemisk blanding af (+)- og (-)-paliperidon.
Pharmacologic group: Psycholeptics, other antipsychotics ATC code: N05AX13 INVEGA contains a racemic mixture of (+)- and (-)-paliperidone.
Farmakoterapeutisk klassifikation: Psykoleptika, andre antipsykotika, ATC-kode: N05AX13 INVEGA indeholder en racemisk blanding af (+)- og (-)-paliperidon.
Pharmacologic group: Psycholeptics, other antipsychotics ATC code: N05AX13 INVEGA contains a racemic mixture of (+)- and (-)-paliperidone.
Farmakoterapeutisk klassifikation: Psykoleptika, andre antipsykotika, ATC-kode:N05AX12 Virkningsmekanisme
Pharmacotherapeutic group: Psycholeptics, other antipsychotics, ATC code: N05AX12 Mechanism of action
Farmakoterapeutisk klassifikation: Psykoleptika, antipsykotika, ATC-kode: N05AH05 Virkningsmekanisme
Pharmacotherapeutic group: Psycholeptics, antipsychotics, ATC code: N05AH05 Mechanism of action
Farmakoterapeutisk klassifikation: Psykoleptika, antipsykotika.
Pharmacotherapeutic group: Psycholeptics, antipsychotics.
Farmakoterapeutisk klassifikation: Psykoleptika, dazepiner, oxazepiner, thiazepiner og oxepiner.
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines.
Farmakoterapeutisk klassifikation: Psykoleptika, diazapiner, oxazapiner, og thiazepiner og oxepiner, ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterapeutisk klassifikation: Psykoleptika, diazapiner, oxazapiner, thiazepiner og oxepiner, ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterapeutisk klassifikation: Psykoleptika, diazapiner, oxazapiner, thiazepiner og oxepiner, ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.3
Farmakoterapeutisk klassifikation: Psykoleptika, diazapiner, oxazepiner, og thiazepiner og oxepiner ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterapeutisk klassifikation: Psykoleptika, diazapiner, oxazepiner, thiazepiner og oxepiner, ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner , thiazepiner og oxepiner.
Pharmacotherapeutic group: pscholeptics, diazepines, oxazepines, thiazepines and oxepines.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner , thiazepiner og oxepiner.
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines thiazepines and oxepines.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner, og thiazepiner og oxepiner ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner, og thiazepiner og oxepiner,ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner, thiazepiner og oxepiner.
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines thiazepines and oxepines.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner, thiazepiner og oxepiner.
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner, thiazepiner, ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code: N05AH03.
Farmakoterapeutisk klassifikation: Psykoleptika, diazepiner, oxazepiner. thiazepiner og oxepiner, ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterapeutisk klassifikation: Psykoleptika, melatoninreceptoragonister, ATC-kode: N05CH03: Virkningsmekanisme
Pharmacotherapeutic group: Psycholeptics, melatonin receptor agonists, ATC code: N05CH03 Mechanism of action
Farmakoterapeutisk klassifikation: rotavirus-diaré-vacciner, ATC-kode: J07BH01 Beskyttende effekt for lægemiddelformen frysetørret pulver
Pharmaco-therapeutic group: rotavirus diarrhoea vaccines, ATC code: J07BH01 Protective efficacy of the lyophilised formulation
Farmakoterapeutisk klassifikation: rotavirus-diaré-vacciner, ATC-kode: J07BH01 Beskyttende effekt for lægemiddelformen pulver og solvens
Pharmaco-therapeutic group: rotavirus diarrhoea vaccines, ATC code: J07BH01 Protective efficacy of the lyophilised formulation
Farmakoterapeutisk klassifikation: Selektiv østrogenreceptormodulator, ATC-kode: G03XC05.
Pharmacotherapeutic group: Selective oestrogen receptor modulator; ATC code: G03XC05.
Farmakoterapeutisk klassifikation: selektive immunsuppressiva, ATC-kode: L04AA24
Pharmacotherapeutic group: selective immunosuppressants, ATC code: L04AA24 Abatacept is a fusion protein that consists of the extracellular domain of human cytotoxic T
Farmakoterapeutisk klassifikation: Selektive immunsuppressiva, ATC-kode: L04AA27 Virkningsmekanisme
Pharmacotherapeutic group: Selective immunosuppressants, ATC code: L04AA27 Mechanism of action
Farmakoterapeutisk klassifikation: Selektivt immunsuppressivum, ATC-kode: L04AA31.
Pharmacotherapeutic group: Selective immunosuppressants, ATC Code: L04AA31.
Farmakoterapeutisk klassifikation: Sensibilisatorer til fotodynamisk/stråle-terapi, ATC-kode: L01XD01
Pharmacotherapeutic group: Sensitizers used in photodynamic/radiation therapy, ATC code: L01XD01‌
Farmakoterapeutisk klassifikation: Stoffer, der virker på renin-angiotensin-systemet, reninhæmmer (aliskiren) kombinationer med diuretika (hydrochlorthiazid), ATC-kode: C09XA52
Pharmacotherapeutic group: Agents acting on the renin-angiotensin system; renin inhibitor (aliskiren) combinations with diuretics (hydrochlorothiazide), ATC code: C09XA52
Farmakoterapeutisk klassifikation: Stoffer, der virker på renin-angiotensin-systemet, reninhæmmere, ATC-kode: C09XA53
Pharmacotherapeutic group: Agents acting on the renin-angiotensin system, renin inhibitors, ATC code: C09XA53
Farmakoterapeutisk klassifikation: Taxaner, ATC-kode: L01CD 02 Virkningsmekanisme
Pharmacotherapeutic group: Taxanes, ATC Code: L01CD 02 Mechanism of action
Farmakoterapeutisk klassifikation: Trombocytfunktionshæmmende midler ekskl. heparin, ATC-kode: B01AC24
Pharmacotherapeutic group: Platelet aggregation inhibitors excluding heparin, ATC code: B01AC24
Farmakoterapeutisk klassifikation: Trombocytfunktionshæmmende midler eksklusive heparin, ATC- kode: B01AC-04.
Pharmacotherapeutic group: platelet aggregation inhibitors excl. heparin, ATC Code: B01AC-04.
Farmakoterapeutisk klassifikation: Trombocytfunktionshæmmende midler eksklusive heparin, ATC- kode: B01AC-04.
Pharmacotherapeutic group: platelet aggregation inhibitors excl. heparin, ATC Code: B01AC04.
Farmakoterapeutisk klassifikation: Trombocytfunktionshæmmende midler eksklusive heparin, ATC- kode: B01AC04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC code: B01AC04.
Farmakoterapeutisk klassifikation: Trombocytfunktionshæmmende midler eksklusive heparin, ATC- kode: B01AC22
Pharmacotherapeutic group: Platelet aggregation inhibitors excluding heparin, ATC code: B01AC22.
Farmakoterapeutisk klassifikation: Trombocytfunktionshæmmende midler eksklusive heparin, ATC-kode: B01AC04.
Pharmacotherapeutic group: Antithrombotic agents, platelet aggregation inhibitors excl. heparin, ATC Code: B01AC04.
Farmakoterapeutisk klassifikation: tumornekrosefaktor-alfa (TNF)-hæmmere, ATC-kode: L04AB02.
Pharmacotherapeutic group: tumour necrosis factor alpha (TNF) inhibitors, ATC code: L04AB02.
Farmakoterapeutisk klassifikation: Ultralydskontrastmiddel ATC-kode: V08DA
Pharmacotherapeutic group: Ultrasound contrast media ATC code: VO8DA.
Farmakoterapeutisk klassifikation: Urologica, alfa-adrenoreceptor-antagonister, ATC-kode: G04CA04.
Pharmacotherapeutic group: Urologicals, alpha-adrenoreceptor antagonists, ATC code: G04CA04.
Farmakoterapeutisk klassifikation: Urologica, urologiske antispasmodica, ATC-kode: G04BD12.
Pharmacotherapeutic group: Urologicals, Urinary antispasmodics ATC code: G04BD12.
Farmakoterapeutisk klassifikation: Urologisk spasmolytika, ATC-kode: G04BD10.
Pharmacotherapeutic group: Urinary antispasmodic, ATC code: G04BD10.
Farmakoterapeutisk klassifikation: Vaccine, andre virale vacciner, ATC-kode: J07BX Virkning hos dyr
Pharmacotherapeutic group: Vaccine, other viral vaccines, ATC code: J07BX Efficacy in animals
Farmakoterapeutisk klassifikation: vaccine, ATC kode : J07CA
Pharmacotherapeutic group : anti infectious, ATC code : J07CA
Farmakoterapeutisk klassifikation: Vaccine, papillomvirusvaccine, J07BM02 Virkningsmekanisme
Pharmaco-therapeutic group: Vaccines, Papillomavirus vaccines, ATC code: J07BM02 Mechanism of action
Farmakoterapeutisk klassifikation: Vacciner, hepatitisvacciner, ATC-kode: J07BC01
Pharmacotherapeutic group: Vaccines, hepatitis vaccines, ATC code J07BC01.
Farmakoterapeutisk klassifikation: Vacciner, kombinerede bakterielle og virale vacciner, ATC-kode: J07CA09
Pharmaco-therapeutic group: Vaccines, Bacterial and viral vaccines combined, ATC code: J07CA09
Farmakoterapeutisk klassifikation: Vacciner, meningokokvacciner, ATC-kode: J07AH08 Virkningsmekanisme
Pharmacotherapeutic group: vaccines, meningococcal vaccines, ATC code: J07AH08 Mechanism of action
Farmakoterapeutisk klassifikation: Vacciner, papillomavirus vacciner, ATC-kode: J07BM03 Virkningsmekanisme
Pharmacotherapeutic group: Vaccines, Papillomavirus vaccines, ATC code: J07BM03 Mechanism of action
Farmakoterapeutisk klassifikation: Vacciner, Virusvaccine; ATC-kode: J07BK02 Virkningsmekanisme
Pharmacotherapeutic group: Vaccines, Viral Vaccine; ATC code: J07BK02 Mechanism of action
Farmakoterapeutisk klassifikation: {endnu ikke tildelt}, ATC-kode: {endnu ikke tildelt}
Pharmacotherapeutic group: {not yet assigned}, ATC code: {not yet assigned}
Farmakoterapeutisk klassifikation: {Endnu ikke tildelt}, ATC-kode: {endnu ikke tildelt}.
Pharmacotherapeutic group: {Not yet assigned}, ATC code: {Not yet assigned}.
Farmakoterapeutisk klassifikation: {Endnu ikke tildelt}; ATC kode: {endnu ikke tildelt
Pharmacotherapeutic group: {not yet assigned}; ATC code: {not yet assigned}
Farmakoterapeutisk klassifikation: {Endnu ikke tildelt}; ATC kode: {Endnu ikke tildelt}.
Pharmacotherapeutic group: {Not yet assigned}; ATC code: {Not yet assigned}.
Farmakoterapeutisk klassifikation: {kategori}, ATC-kode: endnu ikke tildelt Virkningsmekanisme
Pharmacotherapeutic group: {group}, ATC code: not yet assigned Mechanism of action
Farmakoterapeutisk klassifikation: Øvrige midler til fordøjelsesorganer og stofskifte, Forskellige midler til fordøjelsesorganer og stofskifte, ATC-kode: A16AX10.
Pharmacotherapeutic group: Other alimentary tract and metabolism products, Various alimentary tract and metabolism products, ATC code: A16AX10.
Farmakoterapeutisk klassifikation:Psykoleptika, diazapiner, oxazepiner, og thiazepiner og oxepiner , ATC-kode: N05A H03
Pharmacotherapeutic group: psycholeptics, diazepines, oxazepines, thiazepines and oxepines, ATC code N05A H03.
Farmakoterateupisk gruppe: antibakterielle stoffer til systemisk brug, makrolider.
Pharmacotherapeutic group: antibacterials for systemic use, macrolides.
Farmakoterateupisk klassifikation: Oftalmologiske midler, antiinflammatoriske stoffer, non-steroide, ATC-kode: S01BC10
Pharmacotherapeutic group: Ophthalmologicals, anti-inflammatory agents, non-steroids, ATC code: S01BC10
Farmakoterateupisk klassifikation: Oftalmologiske midler, antiinflammatoriske stoffer, non-steroide, ATC-kode: S01BC10
Pharmacotherapeutic group: Opthalmologicals, Anti-inflammatory agents, non-steroids, ATC code: S01BC10
Farmkokinetiske oplysninger
Pharmacokinetic particulars
Farmokokinetiske egenskaber
Pharmacokinetic properties
Farve til tryk (prægning) – Black S-1-17822/S-1-17823 Shellac-glasur-45 %
Ink used for imprinting - Black S-1-17822/S-1-17823 Shellac glaze-45
Farve til tryk (prægning) – Black S-1-17822/S-1-17823 Shellac-glasur-45 %
Ink used for imprinting - Black S-1-17822/S-1-17823: Shellac glaze-45
Farvebånd Trykknap
Colour coding
farvede prikker i dit synsfelt
coloured dots in your vision
farveforandringer i negle, hud og i munden
changes in the colour of your nails, your skin or the skin inside your mouth
Farveløs og opaliserende suspension.
Colourless and opalescent suspension.
Farveløs opløsning, der kan indeholde halvgennemsigtige til hvide, synlige amorfe proteinlignende panitumumab-partikler.
Colourless solution that may contain, translucent to white, visible amorphous, proteinaceous panitumumab particles.
Farveløs til gul, klar spot-on opløsning til udvortes brug.
Colourless to yellow, clear spot-on solution for external application
Farveløs type I-hætteglas af glas lukket med en klorbutyl gummiprop overtrukket med en fluorpolymer.
Colourless type I glass vial with a chlorobutyl rubber closure coated with a fluoropolymer.
Farveløse hætteglas
Injection vial (glass)
Farveløse hætteglas af type I, 10 ml, 20 ml og 100 ml, lukket med gummiprop og aluminiumkapsel.
Colourless type I glass vial of 10 ml, 20 ml or 100 ml, closed with a rubber stopper and sealed with an aluminium cap.
Farveløse hætteglas à 10 ml, lukket med en grå EPDM gummiprop og forseglet med en violet flip-af aluminiumskappe.
Colourless type I glass injection vial of 10 ml, closed with a grey EPDM rubber stopper and sealed with a flip-off aluminium violet seal.
Farveløse type I-hætteglas a 20 ml
Type I colourless glass vials of 20 ml.
Farveløse type II-hætteglas a 50 ml og 100 ml
Type II colourless glass vials of 50 ml and 100 ml .
Farveløst 10 ml hætteglas (type I) med en bromobutylgummiprop og aluminiumhætte, i papæske.
Colourless Type I glass vials of 10 ml closed with a coated bromobutyl rubber stopper and aluminium cap in a carton box.